Oncology Recent advancements in cancer immunotherapeutics BOSTON UNIVERSITY Hee-Young Park KimSusieCancer affects a wide range of organs and tissues within the body and epidemiologically is forecasted to affect almost half of the world's population. As an industry, cancer therapeutics represent a ...
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last decade, significant advancements in the diagnosis and treatment of lung cancer, particularly NSCLC, have been achieved with the help of molecular translational research. Among the hopeful breakthroughs in the...
These advancements hold promise for improving overall survival outcomes and enhancing quality of life for patients with pancreatic cancer. This commentary summarizes the new advances in systemic therapy for pancreatic cancer in 2023. 展开 关键词: Pancreatic cancer Neoadjuvant therapy Chemotherapy Targeted ...
In this paper, we primarily focus on the recent advancements in TCR-T cell therapy, particularly within the last five years, including the discovery of novel targets, innovative protein engineering methods, ongoing and completed clinical trials, and the evolving trends of TCR-T cell therapy in ...
significant potential for future advancements in cancer management. Herein, this review aims to provide intensive literature on diverse nanocarriers, highlighting their applications as cargos for phytocompounds in cancer. Moreover, it offers an overview of the current advancements in the respective field,...
Recently, the discovery of immune checkpoint inhibitors (ICIs) might has potentially ushered in a new era in cancer treatment, demonstrating remarkable advancements in prolonging the survival rates of patients with metastatic cancer [5]. In 2021, the sales of malignant melanoma and non-small cell ...
cancer treatment [28]. The drugs got approval from United States Food and Drug Administration (US FDA) for the medication of PC has been listed in Table1. The timeline for the development of these drugs and their respective approval year has been presented in Fig.1. Surgical treatments are ...
Advancements in chimeric antigen receptor T-cell (CAR-T) therapy aim to enhance chemotaxis and infiltration into the TME, while efforts continue to reduce cell exhaustion and treatment-related toxicities [39]. Several CAR-T cell products have been approved for treating hematological malignancies [40...
EP: 6.Clinical Implications of Recent Advancements in Immunotherapy for NSCLC EP: 7.Key Updates in the Changing NSCLC Treatment Landscape Recent Videos Exploring Outcomes From TROPION-Lung01 Presented at WCLC 2024 HARMONi-02 Reveals Key Lung Cancer Insights at WCLC 2024 ...
cancer immunoediting which indicated the crucial role of immune escape in tumour development and growth, has wrought a profound revolution in cancer treatment [3]. Immunotherapy was defined as therapeutic methods restoring the normal anti-tumour immune response, restarting the tumour-immune and further ...